IT1109321B - Procedimento per la produzione di derivati imidazolici prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo - Google Patents
Procedimento per la produzione di derivati imidazolici prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivoInfo
- Publication number
- IT1109321B IT1109321B IT51570/78A IT5157078A IT1109321B IT 1109321 B IT1109321 B IT 1109321B IT 51570/78 A IT51570/78 A IT 51570/78A IT 5157078 A IT5157078 A IT 5157078A IT 1109321 B IT1109321 B IT 1109321B
- Authority
- IT
- Italy
- Prior art keywords
- procedure
- contain
- production
- active ingredient
- pharmaceutical compositions
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4353277 | 1977-10-19 | ||
| GB4351277 | 1977-10-19 | ||
| GB398478 | 1978-02-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT7851570A0 IT7851570A0 (it) | 1978-10-18 |
| IT1109321B true IT1109321B (it) | 1985-12-16 |
Family
ID=27254350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT51570/78A IT1109321B (it) | 1977-10-19 | 1978-10-18 | Procedimento per la produzione di derivati imidazolici prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo |
Country Status (12)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55313A (en) * | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
| JPS6047257B2 (ja) * | 1979-07-19 | 1985-10-21 | 旭化成株式会社 | 新規な塩基性物質およびその製造法 |
| US4430445A (en) | 1979-07-19 | 1984-02-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel basic imidazolylmethylstyrene compound, its polymer, a process for the preparation thereof and a use as ion exchange resin |
| JPS5681566A (en) * | 1979-12-05 | 1981-07-03 | Yoshitomi Pharmaceut Ind Ltd | Imidazole derivative |
| GR78234B (enrdf_load_stackoverflow) * | 1981-03-10 | 1984-09-26 | Ciba Geigy Ag | |
| JPS57188570A (en) * | 1981-05-14 | 1982-11-19 | Shionogi & Co Ltd | Benzylazole derivative |
| ZA835967B (en) * | 1982-08-14 | 1985-04-24 | Wellcome Found | Imidazole derivatives and salts thereof,their synthesis,and pharmaceutical formulations |
| US4581370A (en) * | 1983-07-12 | 1986-04-08 | Schering A.G. | Antiarrhythmic imidazoliums |
| JPH0172006U (enrdf_load_stackoverflow) * | 1987-10-31 | 1989-05-15 | ||
| JPH01316365A (ja) * | 1988-03-24 | 1989-12-21 | Shikoku Chem Corp | １−ベンジルイミダゾール化合物、該化合物の合成方法及び該化合物を用いるポリエポキシ樹脂の硬化方法 |
-
1978
- 1978-10-18 AU AU40824/78A patent/AU522055B2/en not_active Expired
- 1978-10-18 IT IT51570/78A patent/IT1109321B/it active
- 1978-10-18 DE DE19782845406 patent/DE2845406A1/de not_active Withdrawn
- 1978-10-18 DK DK464278A patent/DK464278A/da not_active Application Discontinuation
- 1978-10-18 JP JP12830378A patent/JPS5488268A/ja active Granted
- 1978-10-18 IE IE2067/78A patent/IE47749B1/en unknown
- 1978-10-18 MC MC781335A patent/MC1221A1/xx unknown
- 1978-10-18 AT AT0747378A patent/AT370095B/de not_active IP Right Cessation
- 1978-10-18 FI FI783175A patent/FI783175A7/fi not_active Application Discontinuation
- 1978-10-18 CA CA313,653A patent/CA1111433A/en not_active Expired
- 1978-10-18 ZA ZA785863A patent/ZA785863B/xx unknown
- 1978-11-02 IL IL55858A patent/IL55858A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU522055B2 (en) | 1982-05-13 |
| JPS6233227B2 (enrdf_load_stackoverflow) | 1987-07-20 |
| MC1221A1 (fr) | 1979-07-20 |
| IE47749B1 (en) | 1984-06-13 |
| DK464278A (da) | 1979-04-20 |
| ZA785863B (en) | 1980-05-28 |
| IL55858A (en) | 1982-09-30 |
| IE782067L (en) | 1979-04-19 |
| DE2845406A1 (de) | 1979-05-03 |
| AT370095B (de) | 1983-02-25 |
| IL55858A0 (en) | 1979-01-31 |
| IT7851570A0 (it) | 1978-10-18 |
| ATA747378A (de) | 1982-07-15 |
| FI783175A7 (fi) | 1979-04-20 |
| CA1111433A (en) | 1981-10-27 |
| JPS5488268A (en) | 1979-07-13 |
| AU4082478A (en) | 1980-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1107772B (it) | Procedimento per la produzione di complessi macromolecolari prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo | |
| IT7852447A0 (it) | Procedimento per la preparazione di derivati amminici e composizioni farmaceutiche che li contengono eprodotto ottenuto | |
| IT1115800B (it) | Derivati dell'imidazolo relativo procedimento di produzione e composizioni farmaceutiche che li contengono come ingrediente attivo | |
| IT1155862B (it) | Procedimento per la produzione di esteri metilici piridinici sostituiti degli acidi ciclopropancarbossilici prodotto ottenuto e composizioni insetticide che lo contengono come ingrediente attivo | |
| IT1109321B (it) | Procedimento per la produzione di derivati imidazolici prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo | |
| IT7851659A0 (it) | Procedimento per la produzione di polisaccardi per estrazione dai corpi microbici dello haemophilus influenza e prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo | |
| IT7869295A0 (it) | Derivati di fenilisotiocianati particolarmente utili come fungicidi per agricoltura e procedimentoper la loro preparazione | |
| IT7851815A0 (it) | Derivati di naftotriazoli composizioni farmaceutiche che li contengono e procedimento per prepararli | |
| IT1111061B (it) | Procedimento per la produzione di imidazobenzossazine e loro sali prodotto ottenuto e composizioni farmaceutiche che lo contengono come in grediente attivo | |
| IT1114720B (it) | Procedimento per la preparazione di derivati di 2-fenilimmino-imidazolidine composizioni farmaceutiche che li contengono e prodotto ottenuto | |
| IT1203108B (it) | Procedimento per la preparazione di derivati di dipertidi e relativi prodotti ad uso farmaceutico | |
| IT7948266A0 (it) | Procedimento per la preparazione di derivati di bicicloottano e di composizioni farmaceutiche che li con tengono e prodotto ottenuto | |
| IT7850986A0 (it) | 5-imminodaunomicina e suoi derivati procedimento per prepararla nonche'composizioni farmaceutiche che la contengono | |
| IT7829133A0 (it) | Derivati del6-ossigenato-3,20-diossopregnano, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
| IT7850877A0 (it) | Procedimento per la produzione dipeptidi analoghi alla somatostatina prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo | |
| IT1111063B (it) | Procedimento per la produzione di derivati originali di 5h-benzo-cicloepten-7-ammina e loro sali prodotto ottenuto e composizioni farmaceutiche che lo contengono come in grediente attivo | |
| IT8068555A0 (it) | Derivati di 1 2 4 ossadiazolin 5 one procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| IT7852360A0 (it) | Procedimento per la produzione di derivati del tetraciclononano antivirali prodotto ottenuto e composizioni farmaceutiche che li contengono | |
| IT7949743A0 (it) | Procedimento per la preparazione di derivati acetilenici di androst-4ene e composizioni farmaceutiche che li contengono e prodotto ottenuto | |
| IT7948727A0 (it) | Procedimento per la preparazione di derivati di pirrolidincarbossaldei de e piperidincarbossaldeide e prodotto ottenuto | |
| IT7848192A0 (it) | Procedimento per la produzione di derivati di 9-2-idrossietossimetilguanina e prodotto ottenuto | |
| IT1110876B (it) | Procedimento per la preparazione di 1-idrossiaporfin derivati e prodotto ottenuto | |
| IT1157750B (it) | Procedimento per la preparazione di derivati di acido 1-idrocarbilpirrolo-2-acetico e prodotto ottenuto | |
| IT1110883B (it) | Procedimento per la preparazione di derivati solfossimmidici farmacolo gicamente attivi e prodotto ottenuto | |
| IT7850613A0 (it) | Drost-4-ene procedimento per la lo derivati 17alfa-acetilenici di anro produzione e composizioni farmaceutiche che li contengono come ingrediente attivo |